Core A: Administrative

核心A：行政

• 批准号: 10455687
• 负责人: ERIC P WINER
• 金额: $ 19.18万
• 依托单位: DANA-FARBER CANCER INST
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-17 至 2024-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10455687
• 关键词: Accounting; Advocacy; Advocate; Agreement; Award; Breast; Cancer Center; Clinical; Clinical Data; Clinical Research; Clinical Trials; Collaborations; Communication; Conduct Clinical Trials; Dana-Farber Cancer Institute; Development; Educational Activities; Ensure; Evaluation; Funding; Grant; Infrastructure; Leadership; Monitor; Office Management; Office of Administrative Management; Patient advocacy; Patient-Focused Outcomes; Patients; Preparation; Reporting; Research; Research Activity; Research Personnel; Research Project Grants; Resource Sharing; Resources; Role; Site; Translational Research; Update; Work; career; disorder risk; improved outcome; malignant breast neoplasm; meetings; programs

PROJECT SUMMARY The role of the Administration, Advocacy, Planning and Communication Core (Administrative Core - Core A) is to coordinate and integrate the multiple components of the Dana-Farber/Harvard Cancer Center (DF/HCC) Breast Cancer SPORE and to provide scientific, administrative and fiscal oversight of the SPORE Projects, Cores, the Developmental Research Program (DRP) and the Career Enhancement Program (CEP). Administrative Management: Core A will facilitate the coordination of the Breast SPORE within the DF/HCC to meet our scientific aims. Core A will provide the infrastructure for fiscal and administrative oversight for the Breast Cancer SPORE, including financial accounting and reporting, coordination of research agreements and pre-and post-award monitoring and reporting in close collaboration with the grants management office at Dana-Farber Cancer Institute. Clinical Research Management: Core A will support all investigators in the Breast SPORE conducting clinical trials and facilitate the interaction and collaborations in the preparation, review and activation of clinical studies within the DF/HCC Breast Program and external sites. Integration of SPORE within DF/HCC: Core A will promote coordination and communication between SPORE investigators, the DF/HCC and its leadership, the DF/HCC Breast Program and its established committees that support clinical trial development, review, activation and management, as well as access and use of biospecimens and associated clinical data. Core A will coordinate the Shared Resources Leadership Committee comprised of the core directors, project leaders, patient advocates and DF/HCC investigators, as well as monthly Research-in-Progress meetings for frequent updates on progress in the Breast SPORE. Patient Advocacy: The Core will integrate the work of our large and highly interactive Patient Advocacy Committee into the planning and evaluation of the Breast SPORE, with guidance from Elizabeth Frank, EdM, as co-investigator of Core A. The Core will seek to fully engage the patient advocates in the four SPORE Projects, the DRP, the CEP and the Cores to ensure that the patient perspective is taken into account in the clinical/translational research. Planning and Evaluation: Core A will provide rigorous scientific leadership and oversight for the SPORE Projects, the Cores, the DRP and the CEP. Core A will organize meetings of the Breast SPORE External Advisory Board (EAB) and Internal Advisory Board (IAB) for evaluation on findings and progress across the Breast SPORE.

项目摘要 政府，倡导，计划和沟通核心的作用（行政核心-A核心A）是 协调和整合Dana-Farber/Harvard Cancer Center（DF/HCC）的多个组成部分 乳腺癌孢子，并对孢子项目提供科学，行政和财政监督， 核心，发展研究计划（DRP）和职业增强计划（CEP）。 行政管理：核心A将促进DF/HCC内乳腺孢子的协调 满足我们的科学目标。核心A将为乳房提供财政和行政监督的基础设施 癌症孢子，包括财务会计和报告，研究协议的协调以及前以及 与Dana-Farber的赠款管理办公室密切合作的授予后监视和报告 癌症研究所。 临床研究管理：核心A将支持乳腺孢子进行临床的所有研究人员 试验并促进临床研究的准备，审查和激活中的相互作用和协作 在DF/HCC乳房计划和外部站点中。 DF/HCC内孢子的整合：核心A将促进孢子之间的协调和交流 调查人员，DF/HCC及其领导层，DF/HCC乳房计划及其既定委员会 支持临床试验开发，审查，激活和管理以及访问和使用 生物测量和相关的临床数据。核心A将协调共享资源领导委员会 由核心董事，项目负责人，患者拥护者和DF/HCC调查人员组成 进行研究的会议，以频繁更新乳腺孢子的进度。 患者倡导：核心将整合我们大型且高度互动的患者倡导的工作 EDM Elizabeth Frank的指导 核心A的共同投资者A核心将寻求完全吸引患者拥护者参与四个孢子项目， DRP，CEP和核心，以确保患者的观点在 临床/翻译研究。 计划和评估：核心A将为孢子提供严格的科学领导和监督 项目，核心，DRP和CEP。核心A将组织外部乳腺孢子的会议 顾问委员会（EAB）和内部咨询委员会（IAB），以评估整个发现和进步 乳腺孢子。